FDA Announces New Gilenya Restrictions for Heart Patients
U.S. health regulators have issued new restrictions for Gilenya, Novartis AG’s' pill for treating multiple sclerosis. According to a Drug Safety Communication issued by the Food & Drug Administration (FDA) yesterday, Gilenya is now contraindicated (FDA advises against its use) in patients with certain pre-existing or recent … [Read more...] about FDA Announces New Gilenya Restrictions for Heart Patients
Drug Watchdog Calls on FDA to Restrict Gilenya MS Drug
A drug watchdog has called on the U.S. Food & Drug Administration (FDA) to restrict multiple sclerosis drug, Gilenya, following patient deaths. We recently wrote that doctors were backing off prescribing multiple sclerosis (MS) medication, Gilenya (gingolimod) amid a number of safety woes. Manufactured by Novartis AG, Gilenya … [Read more...] about Drug Watchdog Calls on FDA to Restrict Gilenya MS Drug
